News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
154 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17699)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Policy
J&J Terminates Two Drugs From Pipeline
Buried in its third-quarter financial announcement, J&J indicated it was dropping two of its pipeline drugs with little or no explanation.
October 17, 2017
·
2 min read
·
Mark Terry
Genetown
Gemini Therapeutics Banks $42.5M to Bring Precision Med to AMD
Backed by Atlas Venture, Lightstone Ventures and OrbiMed, Gemini has emerged with $42.5M in Series A funding and a focus on rare genetic diseases.
October 17, 2017
·
2 min read
·
Alex Keown
Deals
Amneal and Impax to Marry, Creating the 5th Largest Generics Biz in the U.S.
Amneal and Impax are combining into a new entity that is expected to have the fifth largest generics business in the United States.
October 17, 2017
·
2 min read
·
Alex Keown
Pharm Country
3 Biotechs That Got Huge Boosts From Spark’s FDA Panel Vote
On Oct. 13, the FDA’s Cellular, Tissue and Gene Therapies Advisory Committee unanimously recommended Spark’s Luxturna in a vote of 16 to 0.
October 17, 2017
·
2 min read
·
Mark Terry
Job Trends
Drug R&D Boom Lead Massachusetts Biotech Jobs to Hit an All-Time High
And industry trade group MassBio has the jobs numbers and pipeline data to prove it.
October 17, 2017
·
1 min read
Pharm Country
Phosphorus Announces Launch of Genetic Testing SaaS Platform, Elements
Phosphorus announced today the formal launch of its Elements software suite to power diagnostic genetic testing for laboratories, hospital networks, and other health centers.
October 17, 2017
·
3 min read
Bio NC
CEM Introduces the Future of Molecular Sample Preparation
CEM is pleased to introduce the all new EDGE extraction system for rapid sample preparation of GC/LC samples.
October 17, 2017
·
2 min read
Pharm Country
Celsion Provides Summary of Research and Development Day Held on Thursday, October 12, 2017
The presentations focused on the Company’s research and development program using ThermoDox for the treatment of primary liver cancer, also known as hepatocellular carcinoma or HCC.
October 17, 2017
·
6 min read
Business
Biomerica Reports 1st Quarter Fiscal 2018 Financials
Biomerica reported net sales of $1,444,483 for the three months ending August 31, 2017
October 17, 2017
·
3 min read
Deals
Restoration Robotics, Inc. Announces Closing of its Initial Public Offering
The Company’s common stock began trading on The NASDAQ Global Market on October 12, 2017 under the ticker symbol “HAIR”.
October 17, 2017
·
1 min read
Previous
2 of 16
Next